MarketInOut Stock Screener Log In | Sign Up
 

Johnson & Johnson

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 06/26/2026
Johnson & Johnson stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization575,517 mln
Float2,403 mln
Earnings Date07/15/2026

EPS

8.63
Strong

P / E

29.51
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.08
Caution advised

1-Year Forecast

257
Fairly priced

Relative Strength

90 / 100
Top performer

Business Description

Johnson & Johnson is a global healthcare company founded in 1886 and headquartered in New Brunswick, New Jersey. Through its Innovative Medicine division, it develops and sells prescription treatments across a wide range of medical conditions, including cancer, immune disorders, and heart disease. Its MedTech division supplies medical devices and technologies used in surgery, joint care, eye health, and other clinical settings, serving hospitals, clinics, and healthcare professionals around the world.

Key Fundamentals

EPS8.63
P/E29.51
ROE26.39
RPS39.59
ROIC14.32
ROA10.73
Interest Cover24.82
EBITDA, mln33,714
EV / EBITDA17.39
EV / EBIT22.57
Revenue, mln96,362
EV / Revenue6.08

Financial Strength

Altman Z-Score3.69
Piotroski F-Score 4 / 9
Beneish M-Score-2.08
Price to Intrinsic Value2.18
Price to Lynch Fair Value2.19
1-Year Target Price257
Shiller PE Ratio30.04
Short Ratio3.06
Short % of Float1.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.5% 97 / 100   
1 Month 10.1% 90 / 100   
2 Months 7.8% 57 / 100   
6 Months 25.13% 86 / 100   
1 Year 71.41% 92 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us